Site Performance at a Glance
0+
Active & Completed Studies
0 wk
Average Site Startup Time
0+
Indications We Work With
0%
Minority Patient Enrollment
0
Research Site Locations
What We Bring to Your Study
Site Capabilities Built for Sponsor Confidence
Phase II–IV capabilities with capacity for most trial types — from proof-of-concept through post-marketing. Every capability below maps to what sponsors and CROs evaluate during site selection.
Phase II–IV & All Study Types
Full capabilities across Phase II through Phase IV, from proof-of-concept efficacy studies through post-approval surveillance. Equipped for interventional, observational, open-label, double-blind, and long-term extension studies.
Phase II
Phase III
Phase IV
OLE
Full Clinical Trial Support
End-to-end study management from startup through close-out. Investigator training, dedicated coordination and nursing support, regulatory document management, and complete site operations under one roof.
Investigator Training
Coordination
Nursing Support
Regulatory
Patient Recruitment & Retention
Multi-channel recruitment engine including physician networks, EMR-based pre-screening, community outreach, and digital advertising to drive consistent enrollment across active studies.
Physician Networks
EMR Screening
Digital Campaigns
Community Outreach
Infusion Administration & In-House Pharmacy
Dedicated infusion room with IV infusion pumps and on-site infusion capability. On-site investigational pharmacy with temperature-controlled drug storage and secure limited-access areas for IP management.
Dedicated Infusion Room
IV Pumps
On-Site Pharmacy
Temp-Controlled Storage
Lab Processing & Diagnostics
On-site lab processing area with refrigerated and ambient centrifuges, 12-lead EKG machine, vital signs and height/weight measurement, and basic medical supplies. Access to local reference laboratory for sample analysis.
Refrigerated Centrifuge
Ambient Centrifuge
EKG
Local Lab Access
Safety & Emergency Readiness
Emergency cart, automated external defibrillator (AED), oxygen tank and cannulas, and trained medical staff on-site for every study visit. Proximity to Texas Medical Center provides immediate emergency care access.
Emergency Cart
AED
O₂ Tank & Cannulas
TMC Proximity
Rapid Site Activation
Average 6-week startup from site selection to first patient in. Central IRB, parallel contract/budget/regulatory processing, and experienced regulatory staff eliminate common startup bottlenecks.
Central IRB
Parallel Processing
~6 Weeks to FPI
Quality Assurance & Audit Readiness
Internal QA processes, regulatory document management, and audit-ready filing systems. Supports both remote and on-site monitoring. Staff experienced with FDA inspections and sponsor audit requirements.
Internal QA
Remote Monitoring
Audit Ready
Certified & Experienced Staff
All research staff GCP, IATA, and CCRP certified. Team includes investigators, sub-investigators, research nurses, and coordinators with multi-therapeutic experience and low staff turnover.
GCP
IATA
CCRP
Low Turnover
Technology & Data Management
High-speed internet connectivity, EDC/eCRF workstations, CTMS integration, and secure limited-access areas for confidential documents. Staff experienced across all major EDC platforms and sponsor portals.
High-Speed Internet
EDC Proficient
CTMS
Secure Storage
Dedicated Research Facilities
Purpose-built clinical research space with dedicated exam rooms, infusion suite, lab processing area, and investigational pharmacy. Abundant free parking and accessible by public transportation.
Dedicated Exam Rooms
Infusion Suite
Free Parking
Transit Access
Patient Experience & Retention Support
Patient meal services, bilingual staff (English/Spanish), comfortable waiting areas, and a supportive research environment designed to maximize visit compliance and long-term retention across your study.
Meal Services
Bilingual Staff
Patient Comfort
Retention Focus
This is a summary of core capabilities. Our sites are continuously expanding resources and services to meet evolving sponsor and CRO needs. Contact us for a complete site capabilities overview.
Site Diversity Profile
Built-In Diversity for Your Trial
Diversity of study participants plays an important role. Inclusion of wide patient populations across races, ethnic groups, sex, genders, and ages provides evidence that study products or devices will be safe, effective, and generalizable across the broader target patient pool.
Site Race Profile
African American
40%
Asian
35%
Other
15%
White
10%
Site Ethnicity Profile
Hispanic
55%
Non-Hispanic
45%
90%
Minority Patient Enrollment
Located in Houston's Texas Medical Center corridor — one of the most racially and ethnically diverse metropolitan areas in the U.S. Our patient demographics directly support FDA diversity enrollment guidance and Diversity Action Plan requirements.
Trusted by Leading Sponsors & CROs
AstraZeneca
Novartis
Sanofi
Genentech
Vertex
Amgen
Eli Lilly
Biogen
ACADIA
Alexion
Calliditas
Prokidney
Zenas BioPharma
Dimerix
Maze Therapeutics
AstraZeneca
Novartis
Sanofi
Genentech
Vertex
Amgen
Eli Lilly
Biogen
ACADIA
Alexion
Calliditas
Prokidney
Zenas BioPharma
Dimerix
Maze Therapeutics
Partner With Us
Ready to Add a High-Performing Site?
Whether you're a sponsor placing a Phase II–IV study or a CRO looking for a reliable, diverse, fast-activating site in the Texas Medical Center — let's talk.